L&K Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	112,426	272,576	132,181	202,956	107,379	143,972
Market Cap Growth	-14.43%	106.21%	-34.87%	89.01%	-25.42%	-71.54%
Enterprise Value	105,863	278,305	129,243	200,512	115,624	150,234
Last Close Price	5030.00	12960.00	6630.00	10180.00	7212.36	9679.51
PE Ratio	-	-	13.57	-	-	-
Forward PE	-	25.02	25.02	25.02	25.02	25.02
PS Ratio	2.84	7.00	3.66	6.79	5.43	9.37
PB Ratio	2.17	7.06	3.67	6.64	9.98	5.81
P/TBV Ratio	1.93	6.14	3.19	5.87	9.29	6.19
EV/Sales Ratio	2.68	7.15	3.58	6.71	5.85	9.77
EV/EBITDA Ratio	31.52	79.58	22.88	46.12	-	-
EV/EBIT Ratio	180.80	389.17	41.99	98.58	-	-
Debt / Equity Ratio	0.53	0.50	0.65	0.44	2.34	0.91
Debt / EBITDA Ratio	7.73	5.47	4.14	3.11	-	-
Net Debt / Equity Ratio	0.02	0.33	0.10	0.02	1.13	0.13
Net Debt / EBITDA Ratio	0.26	3.68	0.61	0.17	-1.17	-0.24
Net Debt / FCF Ratio	-0.06	-0.76	-0.43	-0.22	-1.82	-0.31
Asset Turnover	0.40	0.47	0.50	0.52	0.35	0.26
Inventory Turnover	0.20	0.23	0.27	0.24	0.33	0.48
Quick Ratio	0.89	0.65	0.90	1.04	0.50	1.70
Current Ratio	1.64	1.60	1.63	1.95	0.95	3.01
Return on Equity (ROE)	-18.25%	-44.98%	27.47%	-25.34%	-91.33%	-46.30%
Return on Assets (ROA)	0.50%	0.54%	2.64%	2.20%	-14.22%	-16.15%
Return on Invested Capital (ROIC)	1.51%	1.57%	8.11%	7.49%	-49.97%	-41.32%
Return on Capital Employed (ROCE)	1.30%	1.60%	7.00%	5.10%	-86.80%	-32.70%
Earnings Yield	-6.55%	-5.98%	7.37%	-0.92%	-12.69%	-6.72%
FCF Yield	-14.24%	-6.19%	-6.06%	-1.68%	-6.22%	-7.29%
Buyback Yield / Dilution	4.40%	6.53%	-34.13%	-21.04%	-0.07%	-12.57%